Satellos Bioscience Inc.: Satellos Bioscience Announces In-Licensing of New Patent Application
Toronto, Ontario--(Newsfile Corp. - June 29, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine company aimed at developing therapeutics that change the